Stock listing

TASE:BLRX BioLineRX Ltd. מניה‎

Home listing (TASE) of BioLineRX Ltd.

Follow BioLineRX Ltd. into a list and get an email when it puts out news.

Share price · TASE:BLRX

1.10 ILA (agorot) 0.00 (0.0%)

Close on Oct 29, 2026

Past year -47.6% · daily closes, Oct 29, 2025 – Oct 29, 2026, adjusted for splits
Day range
1.10 – 1.10 ILA (agorot)Oct 29, 2026
Volume
100,000 sharesOct 29, 2026
Market cap
32.86M ILSAt the close on Oct 29, 2026 · price × 2.99B shares outstanding
52-week range
1.00 – 2.10 ILA (agorot)Lowest and highest trades, Oct 30, 2025 – Oct 29, 2026
Traded on an average day
45,773 ILSMedian day 2.66M shares · last 3 months, Jul 29, 2026 – Oct 29, 2026
BioLineRX Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TASE:BLRX · Home1.10 ILA (agorot)0.00 (0.0%)100,0001.101.101.101.10Close on Oct 29, 2026
NASDAQ:BLRX$2.03 USD-0.01 (-0.5%)4,992$1.97$2.03$1.96$2.04Close on Oct 27, 2026

Daily closes

Last 3 months, Jul 29, 2026 – Oct 29, 2026 · TASE:BLRX · ILA (agorot), adjusted for splits

DayCloseChange%OpenHighLowVolume
1.100.000.0%1.101.101.10100,000
1.10+0.10+10.0%1.001.101.001,348,066
1.00-0.10-9.1%1.101.201.0011,020,588
1.10-0.10-8.3%1.201.201.10593,428
1.20+0.10+9.1%1.101.201.10103,454
1.100.000.0%1.101.201.103,630,646
1.10-0.10-8.3%1.201.201.009,649,668
1.20+0.10+9.1%1.201.201.202,431,817
1.10-0.10-8.3%1.101.201.107,257,431
1.200.000.0%1.201.301.106,635,983
1.200.000.0%1.201.301.205,015,601
1.200.000.0%1.201.301.209,981,993
1.200.000.0%1.201.301.202,645,741
1.200.000.0%1.201.301.204,154,400
1.200.000.0%1.201.301.20911,840
1.200.000.0%1.301.301.203,583,282
1.20-0.10-7.7%1.301.301.202,863,589
1.30-0.10-7.1%1.301.401.208,709,923
1.400.000.0%1.301.401.30714,283
1.40+0.10+7.7%1.301.401.30373,403
1.300.000.0%1.301.401.301,425,362
1.30+0.10+8.3%1.401.401.301,285,100
1.20-0.10-7.7%1.301.401.203,185,320
1.300.000.0%1.301.401.301,297,651
1.300.000.0%1.301.401.303,025,847
1.300.000.0%1.401.401.303,441,553
1.300.000.0%1.301.401.3014,754,104
1.300.000.0%1.401.401.304,248,734
1.300.000.0%1.301.401.305,113,703
1.30-0.20-13.3%1.401.401.303,957,678
1.500.000.0%1.501.501.305,034,182
1.50+0.10+7.1%1.401.501.4057,112
1.40+0.10+7.7%1.401.501.40395,656
1.30-0.10-7.1%1.401.501.302,343,878
1.400.000.0%1.401.501.303,995,603
1.40-0.10-6.7%1.401.501.405,971,703
1.50+0.10+7.1%1.401.501.4020,148,276
1.40-0.10-6.7%1.501.501.40539,856
1.50+0.10+7.1%1.501.501.50375,762
1.40-0.10-6.7%1.501.601.402,669,881
1.500.000.0%1.601.601.403,611,319
1.50-0.10-6.3%1.601.601.504,398,958
1.60+0.10+6.7%1.601.601.60526,968
1.500.000.0%1.501.601.501,389,466
1.50+0.10+7.1%1.501.601.508,099,666
1.40-0.10-6.7%1.401.501.405,189,336
1.500.000.0%1.501.501.402,988,324
1.500.000.0%1.501.501.40284,428
1.500.000.0%1.501.601.50451,399
1.50-0.10-6.3%1.501.601.406,271,465
1.60+0.20+14.3%1.501.601.503,261,725
1.40-0.20-12.5%1.501.501.40506,133
1.600.000.0%1.501.601.50690,733
1.60+0.10+6.7%1.501.601.501,733,332
1.50-0.10-6.3%1.501.601.50192,880
1.60+0.20+14.3%1.501.601.50271,662
1.40-0.20-12.5%1.501.601.402,184,354
1.60+0.10+6.7%1.501.601.50803,796
1.50-0.10-6.3%1.501.501.50411,032
1.60+0.10+6.7%1.601.601.60433,353
Ticker
TASE:BLRX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TASE
Currency
ILA

What changed lately

Calls

Replays

  • Biolinerx (TASE:BLRX) Q2 2026 Earnings Call

    Mon, Aug 31, 2026 · 8:30 AM ET

    Watch Transcript

  • Biolinerx (TASE:BLRX) Q1 2026 Earnings Call

    Wed, May 27, 2026 · 8:30 AM ET

    Watch Transcript

  • Biolinerx (TASE:BLRX) Q4 2025 Earnings Call

    Mon, Mar 23, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026)

Sep 10, 2026

Closed 1.30 (0.0%) on Sep 10, 2026

BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 27, 2026

Closed 1.50 (+7.1%) on May 27, 2026

BioLineRx to Report First Quarter 2026 Results on May 27, 2026

May 20, 2026

Closed 1.30 (-7.1%) on May 20, 2026

BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)

Apr 28, 2026

Closed 1.20 (0.0%) on Apr 28, 2026

Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma

Apr 8, 2026

Closed 1.30 (0.0%) on Apr 9, 2026

BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)

Mar 26, 2026

Closed 1.30 (0.0%) on Mar 26, 2026

BioLineRx Reports 2025 Financial Results and Provides Corporate Update

Mar 23, 2026

Closed 1.30 (-7.1%) on Mar 23, 2026

BioLineRx to Report 2025 Annual Results on March 23, 2026

Mar 16, 2026

Closed 1.40 (-6.7%) on Mar 16, 2026

BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 24, 2025

Closed 1.90 (+5.6%) on Nov 24, 2025

BioLineRx to Report Third Quarter 2025 Results on November 24, 2025

Nov 18, 2025

Closed 1.80 (-5.3%) on Nov 18, 2025

All BioLineRX Ltd. news

Decks

BioLineRX Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
11 in the last 12 months · 19 in all · newest Sep 10, 2026 · oldest 2025
Calls
15 calls with a replay · 15 with a transcript · latest Aug 31, 2026
Decks
23 decks · latest July 2026

Where BioLineRX Ltd. is listed

ListingExchangeCountryCurrency
TASE:BLRX · Home listing · This pageTASEIsraelILA
NASDAQ:BLRXNASDAQUnited StatesUSD
BOATS:BLRXBOATSUnited StatesUSD
Frankfurt:YP2FrankfurtGermanyEUR
gettex:YP2gettexGermanyEUR
Lang & Schwarz:A41038Lang & SchwarzGermanyEUR
Munich:YP2MunichGermanyEUR
Stuttgart:YP2StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about BioLineRX Ltd.